Title : Anthelmintic niclosamide attenuates pressure-overload induced heart failure in mice.

Pub. Date : 2021 Dec 5

PMID : 34736968






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Oral administration of niclosamide reduced TAC-induced increase of serum IL-6 in heart failure mice. Niclosamide interleukin 6 Mus musculus
2 At the concentrations more than 0.1 muM, niclosamide reduced the increased interleukin- 6 (IL-6) mRNA expression in lipopolysaccharide (LPS)-stimulated RAW264.7 and THP-1 derived macrophages. Niclosamide interleukin 6 Mus musculus
3 At the concentrations more than 0.1 muM, niclosamide reduced the increased interleukin- 6 (IL-6) mRNA expression in lipopolysaccharide (LPS)-stimulated RAW264.7 and THP-1 derived macrophages. Niclosamide interleukin 6 Mus musculus
4 In cultured primary cardiomyocytes and cardiac fibroblasts, niclosamide (more than 0.1 muM) suppressed IL-6- and phenylephrine-induced cardiomyocyte hypertrophy, and inhibited collagen secretion from cardiac fibroblasts. Niclosamide interleukin 6 Mus musculus
5 In conclusion, niclosamide attenuates heart failure in mice and the underlying mechanisms include enhancing mitochondrial respiration of cardiomyocytes, inhibiting collagen secretion from cardiac fibroblasts, and reducing the elevated serum inflammatory mediator IL-6. Niclosamide interleukin 6 Mus musculus